TMCI - Treace Medical Concepts, Inc. Stock Price, Fair Value and News

$2.68-0.02 (-0.74%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

TMCI Price Action

Last 7 days

-11.0%

Last 30 days

-59.3%

Last 90 days

-62.6%

Trailing 12 Months

-68.6%

TMCI RSI Chart

TMCI Valuation

Market Cap

170.8M

Price/Earnings (Trailing)

-3.41

Price/Sales (Trailing)

0.78

Price/Free Cashflow

-6.48

TMCI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TMCI Fundamentals

TMCI Revenue

Revenue (TTM)

218.9M

Rev. Growth (Yr)

11.37%

Rev. Growth (Qtr)

5.97%

TMCI Earnings

Earnings (TTM)

-50.1M

Earnings Growth (Yr)

-6.04%

Earnings Growth (Qtr)

6.38%

TMCI Profitability

Return on Equity

-56.18%

Return on Assets

-25.49%

Free Cashflow Yield

-15.43%

TMCI Investor Care

Shares Dilution (1Y)

2.28%

Diluted EPS (TTM)

-0.8

TMCI Alerts

Losses in recent quarter

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	210.8M	213.8M	218.9M	0
2024	196.0M	198.5M	202.9M	209.4M
2023	155.0M	167.0M	174.7M	187.1M
2022	104.8M	114.1M	125.5M	141.8M
2021	64.8M	77.7M	85.1M	94.4M
2020	43.9M	48.4M	52.9M	57.4M
2019	0	0	0	39.4M

Get all data in R, Python etc through our Historical Stock Data APIs

About Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision; and Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

CEO	Mr. John T. Treace
WEBSITE	treace.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	423

Treace Medical Concepts, Inc. Frequently Asked Questions

What is the ticker symbol for Treace Medical Concepts, Inc.? What does TMCI stand for in stocks?

TMCI is the stock ticker symbol of Treace Medical Concepts, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Treace Medical Concepts, Inc. (TMCI)?

As of Wed Dec 03 2025, market cap of Treace Medical Concepts, Inc. is 170.76 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TMCI stock?

You can check TMCI's fair value in chart for subscribers.

Is Treace Medical Concepts, Inc. a good stock to buy?

The fair value guage provides a quick view whether TMCI is over valued or under valued. Whether Treace Medical Concepts, Inc. is cheap or expensive depends on the assumptions which impact Treace Medical Concepts, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TMCI.

What is Treace Medical Concepts, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, TMCI's PE ratio (Price to Earnings) is -3.41 and Price to Sales (PS) ratio is 0.78. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TMCI PE ratio will change depending on the future growth rate expectations of investors.